The Clinical Utility and Impact of Next Generation Sequencing in Gynecologic Cancers

SIMPLE SUMMARY: Cancer cells harbor many genetic abnormalities, but the key oncogenic pathways that lead to clinically evident cancer require driver mutations termed actionable mutations. These actionable mutations can be detected using genomic profiling or next-generation sequencing tests. This dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruthi, Vijaya Kadam, Khazaeli, Mahyar, Jeyachandran, Devi, Desouki, Mohamed Mokhtar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909263/
https://www.ncbi.nlm.nih.gov/pubmed/35267660
http://dx.doi.org/10.3390/cancers14051352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909263/
https://www.ncbi.nlm.nih.gov/pubmed/35267660
http://dx.doi.org/10.3390/cancers14051352

Ejemplares similares